You just read:

New Phase 3 Data Show Anti-TNF Alpha SIMPONI ARIA® (golimumab) Significantly Improved Arthritis And Skin Manifestations In Patients With Active Psoriatic Arthritis

News provided by

Janssen Pharmaceutical Companies

Jun 14, 2017, 07:00 ET